Haas Jason

Track

Insider profile

Performance

Overall performance
1.0
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -17% 8.2% 15.1%
Success rate 10% 68% 82%
Transactions
7 57% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -87%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Haas Jason's trades of Ligand Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-15 2026-06-12
S Sale
45,267 +31.1%
444.21
US$3,735,462 		45,267 +31.1% 444.21 US$3,735,462
2026-06-15 2026-06-12
S Sale
70,661 -15.3%
345.97
US$1,044,936 		70,661 -15.3% 345.97 US$1,044,936
2026-06-12 2026-06-12
PrS Proposed sale
17,390
478.17
US$483,507 		17,390 478.17 US$483,507
2026-05-11 2026-05-08
B Purchase
1,000 +1.6%
20.00
US$20,000 		1,000 +1.6% 20.00 US$20,000
2024-11-20 2024-11-18
S Sale
137,803 -100.0%
0.21
US$28,980 		137,803 -100.0% 0.21 US$28,980
2024-11-18 2024-11-18
PrS Proposed sale
37,803
0.23
US$8,669 		37,803 0.23 US$8,669
2024-11-18 2024-11-18
PrS Proposed sale
100,000
0.20
US$20,310 		100,000 0.20 US$20,310
2024-09-12 2024-09-12
B Purchase
45,344 +57.2%
1.68
US$76,006 		45,344 +57.2% 1.68 US$76,006
2024-09-12 2024-09-11
B Purchase
19,293 +32.2%
1.58
US$30,446 		19,293 +32.2% 1.58 US$30,446
2024-09-12 2024-09-10
B Purchase
35,363 +144.0%
1.55
US$54,788 		35,363 +144.0% 1.55 US$54,788